EverSource Wealth Advisors’s Q32 Bio QTTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.06K Sell
240
-4,400
-95% -$36.8K ﹤0.01% 3523
2026
Q1
$29.8K Hold
4,640
﹤0.01% 2248
2025
Q4
$15.4K Sell
4,640
-385
-8% -$1.09K ﹤0.01% 2560
2025
Q3
$9.95K Sell
5,025
-276
-5% -$530 ﹤0.01% 2824
2025
Q2
$7.9K Buy
5,301
+5,209
+5,662% +$8.88K ﹤0.01% 2958
2025
Q1
$152 Buy
92
+90
+4,500% +$242 ﹤0.01% 3749
2024
Q4
$7 Buy
+2
New +$63 ﹤0.01% 3738

Other funds holding QTTB

EverSource Wealth Advisors's QTTB Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Q32 Bio (QTTB) stake by 95% in Q2 2026, selling an estimated $36.8K and leaving 240 shares worth $3.06K. The position accounts for ﹤0.01% of the portfolio, ranked #3523.

EverSource Wealth Advisors first reported a position in QTTB in Q4 2024 and has held it in 7 quarters since. The position peaked at $29.8K in Q1 2026. 15 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • EverSource Wealth Advisors held 240 shares of Q32 Bio worth $3.06K as of Q2 2026.
  • EverSource Wealth Advisors sold 4,400 Q32 Bio shares in Q2 2026, an estimated $36.8K.
  • Q32 Bio made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3523 holding.
  • EverSource Wealth Advisors first reported a position in Q32 Bio in Q4 2024 and has held it in 7 quarters since.
  • EverSource Wealth Advisors's Q32 Bio position peaked at $29.8K in Q1 2026.
  • 15 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.